- In Brazil, four other vaccines are already in trials phase;
- Paraná’s Tecpar has a deal with RDIF as well.
The Brazilian private pharmaceutical company União Quimica said on Friday it has signed an agreement with the Russian Direct Investment Fund (RDIF) to produce Russia’s Sputnik V vaccine against COVID-19 starting in the second half of November. However, the deal still needs Brazil’s health regulator approval, as reported Reuters.
This is the second initiative to produce Sputnik V vaccine in the country, with Paraná’s Technology Institute, known as Tecpar. In Brazil, four other vaccines are already in trials phase.